| 000 | 01719 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517160946.0 | ||
| 264 | 0 | _c20180501 | |
| 008 | 201805s 0 0 eng d | ||
| 022 | _a1538-7836 | ||
| 024 | 7 |
_a10.1111/jth.13758 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaschke, R A | |
| 245 | 0 | 0 |
_aClinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia. _h[electronic resource] |
| 260 |
_bJournal of thrombosis and haemostasis : JTH _c08 2017 |
||
| 300 |
_a1640-1645 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Validation Study | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 | _aClinical Decision-Making |
| 650 | 0 | 4 | _aDecision Support Techniques |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 |
_aFibrinolytic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPlatelet Factor 4 _ximmunology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombocytopenia _xblood |
| 650 | 0 | 4 | _aUnnecessary Procedures |
| 700 | 1 | _aGallo, T | |
| 700 | 1 | _aCurry, S C | |
| 700 | 1 | _aWhiting, T | |
| 700 | 1 | _aPadilla-Jones, A | |
| 700 | 1 | _aWarkentin, T E | |
| 700 | 1 | _aPuri, A | |
| 773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 15 _gno. 8 _gp. 1640-1645 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/jth.13758 _zAvailable from publisher's website |
| 999 |
_c27285069 _d27285069 |
||